News

MitoSense and Uppsala University's Centre for Transplantation Technology Enter into Strategic MOU

GREAT FALLS, Va., Dec. 21, 2022 /PRNewswire/ -- Today, Uppsala University's Centre for Transplantation Technology (CTTM) and US-based...

MitoSense and U.S. Dept. of Veterans Affairs Selected to Present Science at Major Medical Conference

GREAT FALLS, Va., Sept. 12, 2022 /PRNewswire/ -- MitoSense, Inc., a life-science company focused on harnessing the power of mitochondria...

MitoSense Names Former U.S. Ambassador to Switzerland, Ed McMullen, as Senior Advisor to Board

GREAT FALLS, Va., June 9, 2022 /PRNewswire/ -- MitoSense, Inc., a life-science company focused on harnessing the power of mitochondria to...

MitoSense's CRADA and ALS Work Recognized in Congressional Record

U.S. Congressman Neal Dunn publicly recognized work related to MitoSense's research and development of treatments for amyotrophic lateral...

MitoSense and the U.S. Department of Veterans Affairs Enter into Agreement (CRADA)

MitoSense has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Veterans Affairs (VA).

A Tribute to Dr. Robert Elliott: A Pioneer in Cancer and ALS Research

Ginny Dent Bryant posts a tribute to Dr. Elliott as well as lessons she learned from him regarding cancer. You can find both here.

Newsmax Op-Ed: Medical Pioneer Fought Relentlessly for Patients' Lives

Van Hipp recounts the life and works of Dr. Elliott. Read here.